The Nordic Exchange welcomes Exiqon

Today, Exiqon is listed on the Copenhagen Stock Exchange. Exiqon is the tenth company to join the Nordic Exchange’s main market this year.

Exiqon is registered in the Healthcare sector. The biotechnology company is engaged in the development, manufacturing and marketing of products for genetic analysis. The company serves scientists in the pharmaceutical industry and in research laboratories around the world.

Sales of Exiqon's products have doubled the last few years. The same goes for their product offerings, which integrate innovative chemistries with web-based software tools to help scientists achieve rapid and reliable results. The products are based on the company's patented technologies, which Exiqon has a 75 piece portfolio of.

Exiqon’s products are primarily marketed through the webpage www.exiqon.com, but also through the company’s network of distributors, partners and recognised business. Exiqon has its main office in the area called the Medicon Valley, just outside Copenhagen.

”We are happy to welcome Exiqon to the Nordic Exchange. Exiqon is an interesting company, part of an remarkable development. At the same time Exiqon is part of the many biotech companies, which become listed on an exchange. We have 52 companies registered in the Healthcare sector on the main market and 10 on First North,” explains Jan Ovesen, president, OMX Nordic Exchange Copenhagen.

A round lot of shares in Exiqon, whose short name is EXQ, amounts to 200. Exiqon is registered in the Healthcare sector and is a Small Cap company.